ALEXANDRA GALVANO: Open Payments
NPI 1508477472 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 38 payments from 11 companies in 2025. Trend: 2023 $911 · 2024 $464 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $249 |
| Janssen Biotech, Inc. | 3 | $86 |
| Arcutis Biotherapeutics, Inc. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Organon LLC | 4 | $48 |
| Amgen Inc. | 2 | $44 |
| UCB, Inc. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: SKYRIZI, TREMFYA, Zoryve, DUPIXENT, COSENTYX, OTEZLA, Bimzelx, Winlevi.
Industry payments across NY — which companies pay providers there.
